1. Purpose of Our Medical Information
The mission of Stem Cell Therapy Center India is to provide international patients and caregivers with authoritative, honest, and clinically sound educational resources regarding regenerative medicine, cellular biology, and medical travel in India. We aim to empower patients facing complex degenerative, neuromuscular, and autoimmune challenges with transparent insights.
2. Rigorous Fact-Checking and Review Process
Every piece of health and medical content follows a strict four-stage publishing protocol before publication:
- Primary Clinical Research: Content is drafted based on peer-reviewed biomedical literature indexed on PubMed, NCBI, ClinicalTrials.gov, and official guidelines from bodies such as the International Society for Stem Cell Research (ISSCR).
- Specialist Medical Review: A licensed physician or hematologist evaluates the draft to ensure clinical precision, accurate physiological explanations, and appropriate risk disclosures.
- Regulatory Verification: Content is vetted to ensure conformity with the National Guidelines for Stem Cell Research promulgated by the Indian Council of Medical Research (ICMR) and the Department of Biotechnology (DBT), Government of India.
- Routine Audits & Timestamping: Content is re-reviewed whenever new clinical trials publish meaningful updates or when regulatory directives change.
3. Prohibited Content & Honest Medical Claims
We adamantly reject misleading health claims. In strict adherence to YMYL (Your Money or Your Life) standards:
4. Sources and Citations
We prioritize evidence from:
- Peer-reviewed medical journals with high impact factors (The Lancet, Nature Medicine, Stem Cells Translational Medicine).
- Statutory health organizations: Indian Council of Medical Research (ICMR), Central Drugs Standard Control Organisation (CDSCO), US FDA, EMA, and WHO.
- Accredited academic medical centers and university hospital registries.
5. Commercial Independence & Patient Advocacy
While our center facilitates medical tourism and patient treatment scheduling with NABH and JCI-accredited hospitals in New Delhi, Mumbai, Bangalore, and Chennai, our clinical guidance remains strictly patient-centric. Treatment candidates undergo preliminary evaluations to assess suitability and safety prior to traveling to India.
6. Corrections and Feedback
We welcome peer review, clinician feedback, and patient inquiries. If you believe any information on our website is inaccurate, outdated, or requires clarification, please contact our Editorial Desk directly at contact@stemcelltherapyinindia.com.